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Microglia are the resident macrophage population of the central nervous system (CNS).
Adequate microglial function is crucial for a healthy CNS. Microglia are not only the first
immune sentinels of infection, contributing to both innate and adaptive immune responses
locally, but are also involved in the maintenance of brain homeostasis. Emerging data are
showing new and fundamental roles for microglia in the control of neuronal proliferation
and differentiation, as well as in the formation of synaptic connections. While microglia
have been studied for decades, a long history of experimental misinterpretation meant that
their true origins remained debated. However, recent studies on microglial origin indicate
that these cells in fact arise early during development from progenitors in the embryonic
yolk sac (YS) that seed the brain rudiment and, remarkably, appear to persist there into
adulthood. Here, we review the history of microglial cells and discuss the latest advances
in our understanding of their origin, differentiation, and homeostasis, which provides new
insights into their roles in health and disease.
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INTRODUCTION
Microglia are the resident mononuclear phagocytes of the cen-
tral nervous system (CNS), belonging to the glial system of
non-neuronal cells that support and protect neuronal functions.
Microglia are broadly distributed throughout the brain and the
spinal cord (Lawson et al., 1990), and account for 5–20% of the
total glial cell population within the CNS parenchyma (Perry,
1998). Adequate and appropriate microglial function is crucial
for the homeostasis of the CNS in both health and disease (Perry
et al., 2010).
There are two main functional aspects of microglia: immune
defense and CNS maintenance. As immune cells, they act as sen-
tinels, detecting the first signs of pathogenic invasion or tissue
damage in this delicate immune-privileged site that is actively
protected by the brain blood barrier (Daneman, 2012). Under
the inflammatory conditions of an active immune response how-
ever, microglia must also moderate the potential damage to
the CNS and support tissue repair and remodeling. Perhaps
unsurprisingly, dysregulated microglial activation and microglia-
induced inflammation is observed in virtually all brain patholo-
gies; emerging evidence suggests that microglia exert direct effects
on neurons, contributing to disease progression (Perry et al.,
2010; Kettenmann et al., 2011; Kingwell, 2012).
In recent years there has been an increasing appreciation of
the importance of microglia for normal CNS function. In addi-
tion to their immune functions, emerging data are showing
new and fundamental roles for microglia in the control of neu-
ronal proliferation and differentiation as well as in the formation
of synaptic connections (Graeber, 2010; Hughes, 2012). In the
steady state, microglial cells constantly survey their local microen-
vironment, extending their motile processes to make transient
contact with neuronal synapses, contributing to the modification
and the elimination of synaptic structures (Tremblay et al., 2010).
Microglia also contribute to the remodeling of post-natal neural
circuits as they have been recently shown to play a role in synaptic
pruning during post-natal development in mice (Paolicelli et al.,
2011).
Thus, microglia occupy a central position in the defense and
maintenance of the CNS and so are attracting interest as potential
therapeutic targets in neurological disorders and recovery from
brain injury. However, in order to exploit the abilities of the
microglial population, we must first understand their origins and
homeostasis before attempting to manipulate their functions. In
this review we will present the latest advances in our knowledge
on the origin of microglia, revisit early studies in light of recent
developments and highlight some of the most relevant strategies
to generate microglia for therapeutic approaches of neurological
disorders.
HISTORICAL PERSPECTIVES ON THE NATURE OF MICROGLIA
Defining the origin of microglia has been an elusive goal for
generations of researchers and a longstanding issue of debate.
Multiple schools of thought have emerged. The first descrip-
tion of the cells came from the work of Franz Nissl in the late
nineteenth century, who described rod cells (“Stabchenzellen”) as
reactive glial elements with migratory, phagocytic and prolifera-
tive potential. In the late nineteenth century, W. Ford Robertson
introduced the term “mesoglia” to describe mesoderm-derived
phagocytic elements in the nervous system that had origins dis-
tinct from those of neurons and neuroglia. Neuroglia were first
described by Virchow, in 1856, who named them “nevernkitt”
meaning nerve-glue, later translated as “neuroglia,” though in fact
they corresponded to the macroglial population, which comprises
astrocytes and oligodendrocytes (Rio-Hortega, 1939). While this
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idea had merit, in fact, Robertson’s mesoglia similarly turned
out to correspond mainly to oligodendrocytes. Santiago Ramon
y Cajal later renamed the same cells the “third element of the
nervous system” to further differentiate them from neurons and
neuroglia, and stated that they were of probable mesodermal ori-
gin. This “third element” concept was refined further in 1919
by del Rio-Hortega, a student of Ramon y Cajal, who made
the distinction between various cell types within the cells of the
“third element” based on morphological and functional differ-
ences. Del Rio-Hortega introduced the term “microglial cell” to
describe the non-neuronal, non-astrocytic third element as dis-
tinct from neurectodermal oligodendroglia or oligodendrocytes
(Rio-Hortega, 1939) (For historic review see Rezaie and Male,
2002).
Although both W. Ford Robertson and Santiago Ramon y
Cajal suspected a mesodermal origin of what were to become
known as “microglial cells” (their mesoglia/third element of the
nervous system), it was commonly held at the time that all glial
cells were of neuro-ectodermal origin. Further dissecting the
heterogeneity of the mesoglia, del Rio-Hortega was the first to
introduce the term “microglia” to discriminate true mesodermal
elements from oligodendrocytes, which were previously consid-
ered a component of the mesoglia. Del Rio-Hortega exploited
silver staining techniques to describe the two types of cells as
differing in origin, distribution, form, and function: the major
population, called oligodendroglia, that lacked phagocytic activ-
ity, and the minor population of ramified resting cells. This minor
population was then clearly defined as the “third element of the
CNS” with a mesodermal origin, containing phagocytic corpus-
cles and with migratory and phagocytic activity (Rio-Hortega,
1932).
Despite del Rio-Hortega’s seminal work, his theories were
largely overlooked and have only recently come back to the fore-
front of scientific thinking (Rezaie and Male, 2002). At the time,
there was much support for the belief that microglia shared a
neuro-ectodermal origin with the other glial cells. Several stud-
ies supported this belief well into the twentieth century, including
reports from Fujita who proposed a common, matrix-derived
progenitor for microglia, astrocytes, and oligodendrocytes (Fujita
and Kitamura, 1975). The work of Kitamura was similarly inter-
preted to indicate that microglia, as well as astrocytes, originated
fromneuro-ectodermal-derived glioblasts (Kitamura et al., 1984).
As late as the 1990’s, new studies continued to emerge that
seemed to show a common origin of astrocytes and microglia;
Hao reported that cultures of either murine embryonic neuro-
epithelial cells or astrocytes could differentiate in vitro to give
microglial-like cells, an idea which was supported by Fedoroff ’s
work showing that clonal cultures of disaggregated neopallial cells
from newborn mice gave rise to mixed microglial-astroglial cells
(Hao et al., 1991; Fedoroff et al., 1997). In addition, data show-
ing that donor bone marrow cells failed to contribute to the adult
microglial population in either newborn (De Groot et al., 1992)
or adult rodents (Matsumoto and Fujiwara, 1987) was interpreted
to mean that the majority of microglial cells were of local neuro-
ectodermal origin. However, this interpretation was soon updated
in response to the finding that microglia (in contrast to other
blood leucocyte populations) are highly radio-resistant. In 1993,
Lassmann and co-workers were the first to demonstrate that res-
ident microglia in rats are a very stable cell pool, in contrast to
meningeal and perivascular macrophages, which in adult animals
are only exceptionally replaced by circulating blood cells, even
after recovery from severe brain inflammation (Lassmann et al.,
1993). Such observations were later confirmed in mice by Priller,
where the majority (85–95%) of microglial cells remained of host
origin up to 15 weeks after bone marrow transplantation (Priller
et al., 2001). The importance of the observation that newborn
microglia are not replaced by donor bone marrow-derived cells
(De Groot et al., 1992) will be discussed later, as it has the sig-
nificant implication that the adult microglial population can be
maintained solely by local radio-resistant precursors which are
present in the brain prior to birth.
Other hypotheses on the origin of microglia included their
derivation from the pericytes associated with blood vessels (Mori
and Leblond, 1969; Baron and Gallego, 1972) or from the
subependyma adjacent to the lateral ventricles (Lewis, 1968).
At the same time, a second school of thought was devel-
oping which paralleled del Rio-Hortega’s original hypothesis.
His conviction of the mesodermal origin of microglia was sup-
ported both by studies coupling light/electron microscopy and
immunohistochemistry, which recognized typical morphologi-
cal features of macrophages in the various stages of microglial
development (Murabe and Sano, 1982), and by the demonstra-
tion that microglial cells reacted positively to antisera recognizing
monocyte/macrophage antigens (Hume et al., 1983; Murabe and
Sano, 1983). Despite the emerging evidence of the relation-
ship of microglia to macrophages, other reports led to variable
interpretations due to a lack of homology between monocytes
and mature microglia in the expression of certain antigens,
complicating the issue (Oehmichen et al., 1979; Wood et al.,
1979). Nevertheless, the data showing phenotypic homologies
between monocytes/macrophages and microglia were eventu-
ally validated by immunohistochemical studies that reported the
specific expression of macrophage markers, including F4/80, Fc
receptor and CD11b in mouse microglia (Perry et al., 1985), as
well as FcGRI, and CD11b in their human counterparts (Akiyama
and McGeer, 1990). Finally, a pivotal genetic study revealed that
mice lacking PU.1, a crucial transcription factor for myeloid cells,
were also devoid of microglia (McKercher et al., 1996; Beers
et al., 2006). This unequivocally established the myeloid nature
of microglia and simultaneously suggested that these cells might
be ontogenetically related to macrophages.
THE ORIGIN(S) OF MURINE MICROGLIA
Although there is a consensus about the myeloid origin of
microglia, much controversy remains regarding the precise nature
of microglial progenitors. Initial studies described the pres-
ence of microglial cells during early development, suggesting
that microglia arise from embryonic progenitors. While del
Rio-Hortega proposed that microglia originate from meningeal
macrophages penetrating the brain during embryonic develop-
ment, many authors including del Rio-Hortega himself, claimed
that brain parenchymal microglia could also be derived from
bloodmonocytes. Monocytes are indeed recruited to the neonatal
and adult brain, in the latter case most often under inflammatory
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conditions, where they can differentiate into microglia-like cells.
This knowledge long supported the prevailing viewpoint that
circulating blood monocytes represent microglial progenitors,
replacing those seeding the brain during embryonic develop-
ment. In fact, until recently, the most consensual hypothe-
sis was that embryonic and peri-natal hematopoietic waves of
microglial recruitment and differentiation occurred in the CNS
(Chan et al., 2007). However, we now know that the situation
is somewhat different. Here, we will describe and discuss the
recent advances in understanding of the origin of microglia, and
will also revisit the data from earlier studies in light of these
developments.
EARLY DEVELOPMENT
In addition to having first described microglia, del Rio-Hortega
also proposed that they might initially arise in the early stages of
development from mesodermal cells of the pia mater, the inner-
most layer of the meninges (the membranes surrounding the
brain and spinal cord). From his work on embryonic brains, he
reported the “migration of embryonic corpuscles from the pia
into the nerve centers” with morphological similarity to lym-
phocytes (Rio-Hortega, 1939). However, del Rio-Hortega also
proposed that “microglia may eventually arise from other related
elements, chiefly the blood mononuclears” based on the similari-
ties in morphology and phagocytic activities of the microglia and
monocytes (Rio-Hortega, 1939), thereby founding the “origin of
microglia” controversy.
The immunohistochemical study conducted by Perry et al.,
more precisely described this phenomenon using macrophage
markers such as F4/80. They concluded that as early as embry-
onic day 16 (E16) of development, macrophage-like cells that
had extravasated into the brain parenchyma were localized in
“hot spots,” from where they subsequently invaded the brain
and differentiated through a series of transitional forms to
finally become ramified microglia (Perry et al., 1985). Other
studies later detected dispersed F4/80 expressing macrophages
distributed within loose connective tissue surrounding the neuro-
ectoderm in E12 rat embryos (Morris et al., 1991). Also in
the rat, amoeboid microglial cells expressing monocytic mark-
ers are present as early as E12 in the neuro-epithelium (Wang
et al., 1996). Interestingly, such embryonic cells were proposed
to be microglial progenitors not only due to the similarities in
phenotype and morphology, but because of their potent prolif-
erative response to mitogenic stimulation in vitro (Alliot et al.,
1991).
Similarly, in human fetuses, microglia-like cells with a range
of morphologies can be detected from as early as 3 weeks of esti-
mated gestational age (EGA) (Hutchins et al., 1990). However, it
appears that maturation of the microglial compartment is ongo-
ing throughout the majority of gestation: colonization of the
spinal cord begins at around 9 weeks, the major influx and distri-
bution of microglia commences at about 16 weeks, and ramified
microglial forms take up to 22 weeks to becomewidely distributed
within the intermediate zone (Rezaie andMale, 1999; Rezaie et al.,
2005). It is only close to term, at 35 weeks, that well-differentiated
microglial populations can be detected (Esiri et al., 1991) (for
review Rezaie, 2003 and Verney et al., 2010).
Altogether, these seminal studies strongly suggested that
microglia derive from embryonic hematopoietic precursors that
seed the CNS prior to birth and, more importantly, before the
onset of bone marrow hematopoiesis. However, the exact tissue
origin and developmental cell lineage of precursors that migrate
to the CNS to give rise to the “first” endogenous wave of microglia
remained unknown and a topic of debate until recently.
MOUSE AND HUMAN EMBRYONIC HEMATOPOIESIS
Amajor challenge in defining the embryonic microglial precursor
was the complication of the dual source of blood cell formation
during embryogenesis. Two major hematopoietic sites contribute
to this process: the extra-embryonic yolk sac (YS) and the fetal
liver (Tavian and Peault, 2005; Orkin and Zon, 2008). In mice,
primitive hematopoiesis initiates in the YS around E7.0, shortly
after the onset of gastrulation, leading mainly to the produc-
tion of erythrocytes and macrophages (Moore and Metcalf, 1970;
Palis et al., 1999; Bertrand et al., 2005). Primitive macrophages
first appear in the blood islands of the mouse YS on the ninth
day of gestation and their pattern of differentiation is unique
in the sense that they do not go through a monocytic inter-
mediate stage, as seen in adult macrophages (Takahashi et al.,
1989). YS-derived primitive macrophages will spread into the
embryo proper through the blood after the circulatory system
has been fully established (from E8.5 to E10) (McGrath et al.,
2003) and migrate to various tissues, including the brain. Once
in the tissues, they differentiate into so-called “fetal macrophage
populations” even before the onset of monocyte production by
the fetal liver (Naito et al., 1990). These fetal macrophages have
high proliferative potential, not only in the YS where they are
produced but also in the tissues that they colonize (Takahashi
et al., 1989; Sorokin et al., 1992; Naito et al., 1996; Lichanska
and Hume, 2000). After E8.5, with the determination of the
intra-embryonic mesoderm toward the hematopoietic lineage,
a new wave of hematopoietic progenitors is generated within
the embryo proper, first in the para-aortic splanchnopleura
(P-Sp) region and then in the aorta, gonads, and mesonephros
(AGM) region (Godin et al., 1993; Medvinsky et al., 1993). The
hematopoietic stem cells generated within the AGM will lead to
the establishment of definitive hematopoiesis (Orkin and Zon,
2008). Around E10.5, YS- and AGM-derived hematopoietic pro-
genitors colonize the fetal liver (Kumaravelu et al., 2002), which
serves as themajor hematopoietic organ after E11.5, generating all
hematopoietic lineages, including monocytes (Naito et al., 1990).
A recent study highlighted further differences between primi-
tive and definitive hematopoiesis, showing that the latter relies
on the transcription factor Myb, while YS-derived macrophages
are Myb-independent. This further underlines the fact that YS-
derived macrophages constitute an independent lineage, distinct
from the progeny of definitive hematopoietic stem cells (Schulz
et al., 2012).
Human hematopoiesis also begins in the YS around day
19 of the EGA, and YS-derived stem cells are similarly lim-
ited/committed to myelo-erythroid development. Hematopoiesis
then moves transitorily to the fetal liver around 4–5weeks EGA,
before being definitively established in the BM approximately at
10.5 weeks EGA (Tavian and Peault, 2005).
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THE YOLK SAC HYPOTHESIS OF MICROGLIAL ORIGIN
Ashwell was the first to report the presence of round and amoe-
boid microglial cells in the fetal mouse cerebellum (Ashwell,
1990) and then in rat forebrain (Ashwell andWaite, 1991) as early
as E11.0. Sorokin soon after detected macrophage-like cells and
their precursors in blood vessels and the embryonic mesenchyme
in rat embryos from 10.5, and noted that the developing brain was
the first organ to be colonized (Sorokin et al., 1992). Interestingly,
cells with the capacity to differentiate into microglia-like cells
in vitro (expressing Mac-1, Mac-3, F4/80 and Fc antigens, with a
macrophage-likemorphology and ultrastructure) can be detected
in the developing neuro-epithelium at days E8.5/E9.0, suggesting
that in mice, the earliest developmental stage at which seeding
of cells with myeloid features occurs in the brain is at E8.5/E9.0
(Alliot et al., 1991). Later reports confirmed the presence at sim-
ilar stages of amoeboid cells expressing macrophage (Alliot et al.,
1999; Ginhoux et al., 2010) and microglial markers (Chan et al.,
2007; Mizutani et al., 2012) in both the cephalic mesenchyme and
the neuro-epithelium, in accordance with the idea that the YS
contributes to microglial genesis.
However, the evidence for a YS origin of such microglial
progenitors was, at first, mixed. Initially, data from one of the
aforementioned in vitro studies were interpreted to support the
hypothesis that these macrophage-like cells that will give rise
to microglia originated from the neuro-ectoderm (Hao et al.,
1991). Takashi and Naito drew a different conclusion after they
described the first emergence of immature macrophages within
blood islands of embryonic YS at fetal day 9 in both mouse
(Takahashi et al., 1989) and rat (Takahashi and Naito, 1993).
Following the establishment of fetal blood circulation, these
cells colonize the embryonic tissues, including the brain rudi-
ment. By [3H]-thymidine autoradiography, YSmacrophages were
shown to possess high proliferative potential, which suggested
that these fetal macrophages were in fact primitive macrophages
from the YS (Takahashi and Naito, 1993). Alliot also clearly
and convincingly proposed that such cells were true microglial
progenitors of YS origin, as, at that stage, the YS is the only
hematopoietic site in the embryo. This group then conclusively
documented the presence of potential microglial progenitors in
the YS and then the brain rudiment, with their numbers increas-
ing dramatically from E9.0/E9.5 until around 2 weeks after birth
(Alliot et al., 1999).
A similar pattern of events is likely observed in humans, where,
from 4.5 weeks gestation, amoeboid microglial cells (charac-
terized by the expression of Iba1, CD68, CD45, and MHC-II)
enter the cerebral wall from the ventricular lumen and the lep-
tomeninges (Rezaie et al., 2005; Monier et al., 2007). In the YS
and mesenchyme at 4–6 weeks after fertilization, two populations
of cells with a dendritic morphology could be distinguished: a
majority that expressed monocyte/macrophage-associated mark-
ers but no detectable HLA-DR antigen, while the minority con-
stitutively expressed MHC class II (HLA-DR and -DP) but no
monocyte/macrophage-associated markers (Janossy et al., 1986).
The emergence of this heterogeneity preceded the formation
of both thymus and bone marrow, suggesting the independent
development of these macrophage populations (for review Verney
et al., 2010).
Interestingly, the YS derivation of microglia appears to be con-
served across diverse species as shown in the zebrafish (Herbomel
et al., 2001), and in avians (Cuadros and Navascues, 1998).
However, what differs in mice is the requirement for a func-
tional blood circulation for the spreading of YS macrophages in
the embryo proper. In zebrafish, this colonization appears inde-
pendent of the blood circulation as YS macrophages first directly
invade the whole cephalic mesenchyme, and from there invade
epithelial tissues including the brain, while other macrophages
enter the blood circulation (Herbomel et al., 1999). Similarly,
using chick-quail blood chimeras, Kurz showed that in avians,
YS macrophages do not penetrate through the wall of embry-
onic CNS vessels, but rather from the pial surface (Kurz et al.,
2001). In contrast, in mouse embryos, there is a clear require-
ment for the circulatory system as E9.5–E10.5Ncx-1−/− embryos,
which lack a heartbeat and therefore have no functional blood
circulation due to a defect in the sodium calcium exchanger 1
(Koushik et al., 2001), also lack microglial progenitors (Ginhoux
et al., 2010), as well as other fetal macrophages. However, this
defect does not affect YS hematopoiesis as Ncx-1−/− embryos
have similar numbers of YS macrophages as their control, normal
phenotype littermates (Ginhoux et al., 2010). Whether murine YS
macrophages enter via the blood circulation directly in the brain
parenchyma or first enter in the cephalic mesenchyme and then
migrate to the neuro-epithelium (Chan et al., 2007) remains to
be clearly defined.
The overall conclusion of these studies in rodents, humans,
and other species is that microglia derive from the YS
macrophages that seed the brain rudiment during early fetal
development (Figure 1). However, these reports could not
exclude the possibility that others progenitors could supersede
the YS contribution. In fact, some data that will be discussed
below, continued to emerge that suggested a requirement for the
contribution of blood-borne cells to both generate the post-natal
microglial compartment, and to maintain it into adulthood.
THE EARLY POST-NATAL CONTRIBUTION OF MONOCYTES
TO THE MICROGLIAL POPULATION
Shortly after birth in rodents, the microglial population expands
dramatically (Alliot et al., 1999; Tambuyzer et al., 2009), leading
to the suggestion that the proliferation of embryonic microglial
cells alone could not account for the steep rise in numbers and
that there must be a fresh influx of cells from another compart-
ment. As initially suggested by del Rio-Hortega, blood monocytes
were believed to invade the CNS in the perinatal period and give
rise to microglia, replacing the embryonic microglial cells.
There was support for this belief from several studies, notably
an early report where round, amoeboid, phagocytic cells were
seen in rat corpus callosum during the first few days of life
and then disappeared coincident with the appearance of rami-
fied microglia. These cells were typical macrophages, but some
displayed features of monocytes, while others appeared to be
transitional between the two types. The authors of this study con-
cluded that circulating monocytes enter the developing brain to
assume the form of ameboid microglia that subsequently evolved
to become ramified microglia (Ling, 1976). Subsequent studies
gave neonatal rats an intra-peritoneal pulse of [3H]-thymidine to
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FIGURE 1 | Brain development and microglial homeostasis. Primitive
macrophages exit the yolk sac blood islands at the onset of circulation
and colonize the neuroepithelium from E9.5 to give rise to microglia. The
blood brain barrier starts to form from E13.5 and may isolate the
developing brain from the contribution of fetal liver hematopoiesis.
Embryonic microglia expand and colonize the whole CNS until adulthood.
Importantly, in steady state conditions, embryonically-derived microglia
will maintain themselves until adulthood, via local proliferation during late
gestation and post-natal development as well as in the injured adult brain
in reaction to inflammation. Nevertheless, during certain inflammatory
conditions found for example after bone marrow transplantation, the
recruitment of monocytes or other bone marrow-derived progenitors can
supplement the microglial population to some extent. However, we do
not understand yet whether these cells persist and become integrated in
the microglial network, or are a temporary addition to the endogenous
population.
allow tracking of labeled blood cells by autoradiography. Labeled
immature amoeboid cells were detected in the corpus callosum
few hours after administration, while the majority of newly-
ramified microglia were labeled one week later. These observa-
tions implied that labeled microglial cells must therefore have
come from the transformation of immature amoeboid cells that
acquired the tracer earlier (Imamoto and Leblond, 1978). This
possibility was further tested by injecting a suspension of car-
bon particles into the circulation of rats of various ages to enable
tracing of carbon-labeled monocytes, or by direct adoptive trans-
fer of carbon-labeled monocytes. Later on, carbon particles were
sequentially found in amoeboid cells of the corpus callosum and
then on ramified microglial cells, suggesting again that blood
monocytes, after ingesting carbon particles in the circulation or
after transfer, migrated to the corpus callosum and differenti-
ated into microglial cells via an amoeboid stage (Ling, 1979; Ling
et al., 1980; Leong and Ling, 1992). However, while such data sug-
gest that circulating blood monocytes can enter the CNS right
after birth, perhaps in a specific site, it is important to note that
such studies were rather qualitative and did not clearly address
the exact relative contributions of post-natal monocytes versus
embryonic progenitors to adult microglial homeostasis. In fact,
the authors had themselves clearly recognized that such events
were infrequent (Ling et al., 1980).
Nevertheless, later studies employing the PU.1 knockout (KO)
mouse model, that lacks embryonic microglia, demonstrated
the capacity of bone marrow-derived cells to contribute to the
post-natal microglial population. In this study, neonates received
wild-type bone marrow transplants within 24 h of birth, which
resulted in de novo generation of the full microglial compartment
(Beers et al., 2006). Therefore, it must be concluded that, at least
under exceptional circumstances such as in the PU.1 KO mouse
where endogenous embryonic microglia are completely absent,
some bone marrow-derived cells have the capacity to infiltrate
the CNS and assume the morphology and phagocytic capacity of
microglia.
A CONTRIBUTION OF MONOCYTES TO THE ADULT MICROGLIAL
POPULATION IN THE STEADY STATE?
Following the observations that monocytes might be able to con-
tribute to the microglial population immediately after birth, it
became implicitly accepted that they could also do so in adults.
The idea that monocytes, or any bone marrow-derived cells,
might then be able to be engineered and used as a delivery system
into the CNS for therapies, the “Trojan Horse” theory, motivated
investigators to discover the underlying mechanisms. The main
hypothesis became that embryonic microglia disappear and are
replaced by post-natal bone marrow-derived cells.
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That is not to say that there were not data supporting
the hypothesis of a role of monocytes in maintaining the
adult microglial population: a seminal study employing [3H]-
thymidine incorporation and autoradiography in normal adult
mice concluded that cells can be recruited from the circulat-
ing monocyte pool through an intact blood-brain barrier (BBB)
and rapidly differentiate into resident microglia (Lawson et al.,
1992). However, the authors also noted that the resident microglia
were proliferating, which suggested that the microglial popula-
tion might maintain itself through either mechanism, or perhaps
both. Other data supporting the idea that adult bone marrow-
derived cells can give rise to microglia included the observation
that following total bone marrow transplantation, some donor
hematopoietic cells differentiated into microglia within the brains
of adult mice (Eglitis and Mezey, 1997; Mezey et al., 2000; Simard
and Rivest, 2004).
However, these results were in slight disagreement with a pre-
vious, and importantly, more quantitative, study which showed
that the majority of microglial cells remained of host origin up
to 15 weeks after bone marrow transplantation in mice (Priller
et al., 2001). Similar results were also initially reported in rats as
several investigators concluded that there was little or no con-
tribution of bone marrow-derived cells to the adult microglial
pool (Matsumoto and Fujiwara, 1987; Lassmann et al., 1993). In
addition, it was shown that while microglia are not bone marrow-
derived in adults, the closely-associated meningeal and perivascu-
lar macrophages are, perhaps going some way to explaining the
confusion. Schelper and Adrian bluntly concluded that “mono-
cytes become macrophages; they do not become microglia,” in
this case, following CNS lesions (Schelper and Adrian, 1986),
while Hickey and Kimura showed that the stable pool of resi-
dent microglia is only exceptionally supplemented by hematopoi-
etic cells, even after recovery from severe brain inflammation
(Hickey and Kimura, 1988). Similarly, Vallieres reported that
many of these cells were in fact perivascular macrophages and
that newly-formed parenchymal microglia were found in signifi-
cant numbers only in the cerebellum and at injury sites (Vallieres
and Sawchenko, 2003). Importantly, in humans, taking advan-
tage of sex-mismatched donor bone marrow transplant (male
into female) where Y-chromosome specific in situ hybridization
can be performed to follow the origin of cells, similar results
were obtained. The only donor male cells detected corresponded
to mononuclear leucocytes within the vessel lumen and infiltrat-
ing the perivascular space and parenchyma, and perivascular cells
(Unger et al., 1993). In fact, the observation that bone marrow-
derived microglia were only found in notable amounts under
certain conditions highlighted some significant shortfalls of the
earlier studies: while it was successfully shown that monocytes
could differentiate into cells that resembled microglia, few had
quantified the effect or attempted to define the phenomenon
in space and time, or to monitor the persistence of the bone
marrow-derived microglia.
A CONTRIBUTION OF MONOCYTES TO THE ADULT MICROGLIAL
POPULATION DURING INFLAMMATION?
What became clear was that although the monocyte-to-microglia
path may exist in adult brain, it is unlikely to be a significant
source for maintaining the microglial population, although this
might change during CNS inflammation or disease (Vallieres and
Sawchenko, 2003; Ladeby et al., 2005; Mildner et al., 2007). In
fact, in response to CNS inflammation and damage, an increase
in microglial number is often observed, a phenomenon called
reactive microgliosis, which has become a hallmark of many
CNS pathologies. However, it remained to be elucidated whether
such increases in number rely on local expansion of mature
microglia or are achieved by recruitment of blood precursors such
as monocytes.
Two recent studies clarified the relative contribution of blood
monocytes to microglia in experimental models of CNS patholo-
gies. Both revealed that the irradiation regimen used to prepare
recipient animals for bone marrow transplants is necessary for
the recruitment and differentiation of monocytes into microglia
(Ajami et al., 2007; Mildner et al., 2007). Mildner showed that
recipient mice in which the CNS was shielded to protect from the
irradiation and its associated inflammation, which induces the
release of pro-inflammatory cytokines and chemokines, did not
experience a significant invasion of bone marrow-derived cells
into the brain, in contrast to the unshielded mice (Mildner et al.,
2007). Beyond the irradiation issue, these data also suggest that
microglial engraftment from the blood requires pre-conditioning
of the CNS that likely disrupts the BBB. Additional clarity came
from experiments in parabiotic mice, which have undergone
surgery to physically link their circulatory systems, providing a
more physiological means to study the turnover of hematopoi-
etic cells for prolonged periods without the need for irradiation
(Ajami et al., 2007). Ajami used such mice to show that in con-
trast to what was observed in irradiated and transplanted mice,
there was no microglial progenitor recruitment from the circu-
lation in either denervation or CNS neurodegenerative disease,
despite the fact that the mixing of leucocyte populations can reach
up to 50% in the blood of both parabionts. In agreement with
their findings, we found no contribution of bone marrow-derived
cells to CNSmicroglia up to 12 months after parabiosis (Ginhoux
et al., 2010). Such data suggest that maintenance and local expan-
sion of microglia are solely dependent on the self-renewal of
CNS-resident cells in these models.
Interestingly, with this parabiotic model, in the context of
irradiation of one parabiont, no further contribution from the
other parabiont was detected in contradiction with the results of
Mildner. However, Ajami further clarified that although irradi-
ation is required for donor cells to engraft, it is not sufficient;
another important, but overlooked, requirement is the artificial
introduction of a critical number of bone marrow cells into the
blood circulation (where they are not normally found) in con-
junction with the inflammation of BBB caused by irradiation, a
situation found only upon lethal total bone marrow transplan-
tation (Diserbo et al., 2002; Li et al., 2004; Linard et al., 2004).
More recently, the same group used a similar approach combining
parabiosis and myelo-ablation to show that recruited monocytes
do not persist and therefore do not contribute to the resident
microglial pool. However, recruited monocytes contribute to
the severity of disease in multiple sclerosis and the experimen-
tal autoimmune encephalitis mouse model (Ajami et al., 2011).
Similarly, in transgenic mouse models of Alzheimer’s disease,
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irradiation was shown to condition the brain for engraftment
of myeloid cells, a phenomenon that does not occur normally
during disease progression (Mildner et al., 2011). Interestingly,
in this study, perivascular macrophages, rather than microglia
and monocytes, modulated β-amyloid deposition in the brains
of AD transgenic mice by clearing Aβ in a CCR2-dependent
fashion (Mildner et al., 2011). This highlights the distinct and
non-redundant roles of microglia, monocyte, and perivascular
macrophages in acute injury and autoimmune inflammation
(Jung and Schwartz, 2012). Finally, Capotondo recently clarified
that the conditioning regimen also contributes to the ablation
of endogenous microglia, thereby allowing the local proliferation
of invading blood cells (Capotondo et al., 2012). In conclusion,
parabiotic mice provided, for the first time, unequivocal evidence
that the microglial population during the steady state is able
to maintain itself throughout adult life by local renewal, inde-
pendent of circulating precursors in steady state. Conversely, in
transplant models, which are perhaps not so much reflections of
normal physiology, a fraction of microglia can arise from adult
bone marrow.
As discussed before, we know that adult bone marrow cells can
also enter into the CNS and differentiate into microglia in excep-
tional circumstances: when the endogenous microglial niche is
completely vacant, such as in the PU.1 KO (Beers et al., 2006),
or experimentally depleted, for example using Gancyclovir in a
mouse model expressing the thymidine kinase under the CD11b
promoter (Varvel et al., 2012). Importantly, microglial repopula-
tion in the latter study did not require any conditioning regimen
such as irradiation, as the microglial pool reconstituted itself after
cessation of the Gancyclovir treatment. However, the effect of
Gancyclovir on the permeability of the BBB was not evaluated
in this model and we do not know if the bone marrow progeni-
tors require additional “help” in order to cross the BBB, perhaps
through the presence of as yet undefined inflammatory media-
tors. In addition, in their experimental setting, the authors could
not formally track the origin of the cells that repopulate the
microglia and therefore were unable to exclude local repopula-
tion from non-depleted microglial cells. Nevertheless, the fact
that adult bone marrow cells can give rise to microglia in the
context of hematopoietic cell transplantation with a conditioning
regimen open the door for invaluable therapeutic strategies for
the correction of CNS conditions in which defects ofmicroglia are
implicated. For example, bone marrow transplantation of mouse
models for metachromatic leukodystrophy (Biffi et al., 2004),
the obsessive compulsive disorder trichotillomania (Chen et al.,
2010), and Rett syndrome (Derecki et al., 2012) has been shown
to ameliorate disease symptoms.
In conclusion, in these transplant models, which are per-
haps not so much reflections of normal physiology, a fraction of
microglia are of bone marrow origin. However, during the steady
state, monocytes or other bone marrow-derived cells do not enter
the CNS and do not significantly contribute to the microglial
population.
EVIDENCE FOR THE PERSISTENCE OF THE EMBRYONIC WAVE
OF MICROGLIA
What remained unclear in the field, however, was the relative con-
tribution of embryonic and post-natal hematopoietic progenitors
to the steady-state microglial population in adults: are the embry-
onic microglia responsible for maintaining the adult pool or do
embryonic and adult microglia in fact have different origins? One
of the studies already discussed, from De Groot, had implied
that embryonic microglia were the sole contributors to the adult
microglial pool. This study observed that donor bone marrow
cells failed to contribute to the adult microglial population in
a model of newborn transplantation, and concluded therefore
that the adult microglial population was totally independent
of post-natal bone marrow-derived circulating precursors from
birth onward (De Groot et al., 1992). Recently, we revisited their
experiments with a more quantitative aim and found that while
most circulating leucocytes were of donor origin, the majority
of microglia remained of host origin for more than 3 months
after transplantation, confirming that post-natal hematopoietic
precursors, including monocytes, likely do not contribute to the
adult microglial population (Ginhoux et al., 2010).
We also employed a more advanced technique of YS progen-
itor fate mapping to definitively answer this question. Our fate
mapping mouse model expresses a fluorescent protein (eYFP)
exclusively in YS progenitors and their progeny, which include YS
macrophages. Briefly, this mouse model expresses a tamoxifen-
activated MER-Cre-MER recombinase gene under the control of
one of the endogenous promoters of the runt-related transcrip-
tion factor 1 (Runx1) locus (Samokhvalov et al., 2007). When
crossed with a Cre-reporter mouse strain, recombination can be
induced in embryos by a single injection of 4-Hydroxytamoxifen
(4′OHT) into pregnant females. Active recombination in these
knock-in mice occurs in a short time frame that does not
exceed 24 h post-injection and leads to irreversible expression of
eYFP in Runx1+ cells and their progeny (Samokhvalov et al.,
2007).
Although both YS and fetal liver hematopoietic progeni-
tors express Runx1, YS progenitors are the only cells present
at E7.5 and so injection of tamoxifen at E7.5 will therefore
allow the specific and irreversible tagging of YS progenitors and
their progeny but not of fetal liver-derived progeny. In con-
trast, injection of tamoxifen at later time points (from E8.5)
will favor the tagging of AGM-derived hematopoietic progeni-
tors and not the YS progenitors (North et al., 1999; Samokhvalov
et al., 2007). We can use this model to accurately ask about
the origins of different cell types; for example, in the case of
microglia, if they are predominantly derived from YS tagged
progenitors, they should express eYFP in the adult CNS when
4′OHT is injected at E7.5 and not at E8.5. In contrast, circu-
lating leukocytes, including monocytes that are known to derive
from AGM hematopoietic progenitors, will present the opposite
profile, expressing eYFP when 4′OHT is injected at E8.5 instead
of E7.5. In addition, if the microglial population does predom-
inantly derive from YS progenitors without a significant contri-
bution from fetal liver- or bone marrow-derived hematopoiesis,
they should be tagged at a higher level than circulating leuko-
cytes, which derive predominantly from mature hematopoiesis.
To test this hypothesis, we injected the mice with tamoxifen
at closely spaced time points of gestation and compared the
number of eYFP-tagged microglia and circulating monocytes in
the mice as adults. Strikingly, the relative number of tagged
microglia in mice injected at E7.25 was much greater than of
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blood monocytes or other circulating leukocytes (Ginhoux et al.,
2010).
In contrast, the relative number of tagged microglia in mice
injected from E8.0 onwards decreased dramatically to reach
undetectable levels as soon as E8.5, while the relative number
of eYFP+ leukocytes, including monocytes, increased progres-
sively in adult blood. This opposing pattern of recombination in
microglia compared to circulating leukocytes strongly supports
the idea that the major contribution to microglial numbers comes
from YS progenitors, and formally excludes the contribution of
definitive hematopoiesis. Altogether these results establish that
microglia originate from E7.25 Runx1 YS-derived hematopoietic
progenitors, with little, if any, contribution from hematopoietic
progenitors arising later in embryonic development. Recent stud-
ies confirmed our findings (Schulz et al., 2012; Kierdorf et al.,
2013). In particular, the latest study from Kierdorf refined the
characterization of the YS precursors that give rise to microglia
and identified them as early E8 primitive c-kit+ erythromyeloid
YS precursors which develop into CD45+c-kitloCX3CR1− cells
before their maturation and migration into the developing brain
as CD45+c-kit-CX3CR1+ cells (Kierdorf et al., 2013).
Altogether, these studies conclusively demonstrated that prim-
itive macrophages are the embryonic source of the steady-state
adult microglial population, which was particularly interesting
as it implied that microglia not only have a unique func-
tional specialization within the CNS, but also a unique ori-
gin, arising from YS progenitors that maintain themselves by
proliferating in situ throughout adulthood (Figure 1). Beyond
the case of microglia, it also provided startling evidence for a
broader conclusion, that primitive macrophages are the ulti-
mate source of a functional immune compartment that persists
throughout adulthood. However, the case of the microglia seems
to be unique, as other fetal macrophage populations in the
embryo will mostly be replaced by fetal liver-derived monocytes
that seed the tissues later and differentiate into macrophages,
as we have recently shown in the case of Langerhans cells
(Hoeffel et al., 2012). Lack of differentiation of fetal liver-
derived monocytes into microglial progenitors could result from
their lack of intrinsic differentiation potential or lack of access
to the developing brain. Corroborating the latter hypothesis,
the BBB in rodents is starting to be established at approx-
imately E13.5, at the time of fetal liver monocyte release
into the blood circulation (Daneman et al., 2010), but after
YS-derived macrophages start to invade the neuro-epithelium
from E9.5 (Ginhoux and Merad, 2010), possibly restricting
the access of fetal liver-derived cells to the embryonic brain
(Figure 1).
MOVING TOWARD HARNESSING MICROGLIA TO IMPROVE
HUMAN HEALTH
It is well established that microglia are intimately involved in the
pathology of neurological disease. However, efforts to elucidate
the specific roles of microglia, their activation phenotypes and
how they can be harnessed to ameliorate disease, are hampered by
the lack of access to sufficient numbers of cells for comprehensive
in vitro studies. Isolation of primary rodent microglia is gener-
ally achieved either by cell sorting or stepwise cell culture, both
of which are time-consuming and generally yield few cells. While
of limited use in rodents, this approach is entirely unfeasible for
obtaining human microglia.
Although there has been some success producing microglia-
like cells from bone marrow stem cells and circulating mono-
cytes, they are perhaps poor models of “true” microglia as these
cell populations do not share the embryonic origin of the vast
majority of microglia in the homeostatic brain. Furthermore,
their relatively advanced states of differentiation also make them
unsuitable for asking questions about the intrinsic and extrin-
sic regulators of microglial development and specification. In
contrast, pluripotent stem cells are already widely used in inves-
tigations of embryonic development, have undergone directed
differentiation into astrocytes and neuronal subtypes of the CNS,
and even been used for cellular transplantation therapies for neu-
rodegenerative diseases (Park et al., 2008a; Kiskinis and Eggan,
2010; Wu and Hochedlinger, 2011; Ben-David et al., 2012).
The exciting discovery that terminally-differentiated somatic cells
can be reprogrammed into an embryonic-like “induced pluripo-
tent stem cell” (iPSC) has also opened up new possibilities
for disease modeling and developing patient-specific therapies
(Takahashi and Yamanaka, 2006; Okita et al., 2007; Takahashi
et al., 2007; Wernig et al., 2007; Yu et al., 2007; Park et al.,
2008b).
Both embryonic stem cells (ESCs) and iPSCs have vir-
tually unlimited expansion potential, can be cultured under
defined conditions to ensure reproducible and scalable differ-
entiation protocols, and are amenable to genetic manipula-
tion to create tools for deeper functional studies. Large-scale
in vitro generation of microglia would also allow us to per-
form high-throughput genetic screens aiming to uncover key
transcription factors responsible for specifying the microglial
phenotype. Even more attractively, we could potentially dif-
ferentiate iPSCs from human patients to re-create a “disease
in a dish,” forming a crucial bridge between animal models
(which are often deficient) and pathological disease states in
humans. Thus far, efforts to recapitulate neurological disease
features in vitro from human iPSCs have mainly focused on
the afflicted neurons (Dimos et al., 2008; Park et al., 2008b;
Lee et al., 2009; Soldner et al., 2009; Marchetto et al., 2010).
The development of more complex disease models incorpo-
rating multiple cell types, particularly microglia, remains a
challenge.
In contrast to the numerous protocols for efficient gener-
ation of astrocytes and neurons from pluripotent stem cells
(Lee et al., 2000; Zhang et al., 2001; Hu et al., 2010), there is
little literature reporting methods for obtaining phenotypically-
correct microglia from the same cell sources. An early study
on the differentiation of mouse ESCs (mESCs) into CNS
cells in retinoic acid-induced embryoid bodies (EBs) showed
that incidental cells expressing microglial markers were gen-
erated, in addition to neurons and astrocytes (Angelov et al.,
1998). This preliminary success was the motivation for sub-
sequent attempts to generate microglia from mESCs via neu-
ronal differentiation strategies (Tsuchiya et al., 2005; Napoli
et al., 2009). In brief, mESCs were induced to differentiate as
EBs following withdrawal of leukemia inhibitory factor (LIF),
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and then progenitors were expanded and further differenti-
ated with neuronal-supportive media and cytokine stimulation.
After 21–50 days CD45low/CD11b+ putative microglia-like cells
were observed in these cultures; they expressed surface mark-
ers consistent with primary microglia, responded to classical
immune activators such as lipopolysaccharide and interferon-γ,
and appeared to survive implantation into the mouse brain.
However, the low yields and prolonged culture period required,
together with our current understanding of the ontogeny of
microglia, suggest that these microglia-like cells perhaps are
arising as a side population in the neuro-ectodermal differ-
entiation process. On the other hand, we should not dis-
count the possibility that neural cells present in these cultures
might have provided a signaling milieu supportive of genuine
microglial maturation. For example, brain- and bone marrow-
derived Mac-1+ progenitors co-cultured on a supportive layer
of astroglial cells proliferated and matured into microglial-like
cells (Alliot et al., 1991). Sievers and colleagues also showed
that co-culture with astrocytes induced blood monocytes and
spleen macrophages to adopt a ramified morphology akin to
microglia (Sievers et al., 1994a,b). In light of our current under-
standing that adult microglia originate as primitive macrophages
from the embryonic YS, a more effective strategy for approach-
ing pluripotent stem cell differentiation may be to attempt to
recapitulate YS hematopoiesis in vitro (Figure 2). In the mouse,
hemangioblast precursors migrate from the posterior primi-
tive streak into the YS proper, where they form the blood
islands and surrounding endothelial cells (Huber et al., 2004).
YS hematopoiesis yields primitive erythroblasts as early as E7.0,
followed by definitive erythroblasts and macrophage progeni-
tors between E8.5–9.0 (Palis et al., 1999). However, it has been
known for some time that these developmental stages can be
closely mirrored in mESC differentiation in vitro, specifically
in terms of the kinetics of hematopoietic gene expression, as
well as the order in which hematopoietic progenitors appear. In
two modalities of differentiation, either in a co-culture with a
hematopoietic-supportive stromal cell layer such as OP9 cells,
or as EBs, mESCs sequentially generate in vitro equivalents of
the primitive streak, hemangioblast, and YS hematopoietic pro-
genitors (Risau et al., 1988; Wiles and Keller, 1991; Nakano
et al., 1996; Ogawa et al., 1999; Kennedy and Keller, 2003;
Hirai et al., 2005). These processes in mESCs are controlled
by the same molecular regulators as those operative during
early hematopoiesis in vivo. For example, mouse embryos with
targeted gene disruption of the hematopoietic master regula-
tor SCL/Tal-1 have no YS hematopoiesis and fail to develop
beyond E9.5 (Robb et al., 1995; Shivdasani et al., 1995); likewise
abrogation of SCL expression in both mouse and human ESCs
FIGURE 2 | Strategy for directed differentiation of microglial
precursors from pluripotent stem cells. Microglial differentiation
in vitro can be achieved by recapitulating the steps of yolk sac
hematopoiesis. Hemangioblast cells arise in the posterior primitive
streak and migrate into the yolk sac, giving rise to the blood islands.
Primitive erythroblasts are observed from E7.0–7.5, followed by
definitive erythroblasts and primitive macrophages at E8.5. At the
onset of circulation, primitive macrophages exit the yolk sac and seed
the developing brain, forming microglia. Likewise, pluripotent stem cells
can be differentiated into Bry+Flk+ cells with hemangioblast properties;
these cells are then further differentiated into both primitive and
definitive eryothroblasts and primitive macrophages. In vitro-derived
primitive macrophages may be the functional equivalent to primitive
microglia in the embryo.
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completely represses early hematopoietic specification (D’souza
et al., 2005; Real et al., 2012). Similarly, PU.1 KO ESCs could not
be differentiated into macrophages (Henkel et al., 1996; Anderson
et al., 1998), consistent with the finding that PU.1 KO embryos
lack both macrophages and microglia (McKercher et al., 1996).
However, useful the mouse developmental model may be, the
paucity of equivalent human in vivo models makes it imperative
to develop accurate in vitro alternatives using human pluripotent
stem cells. Classical lineage tracing studies of blood development
in human embryos showed that many essential features of YS
hematopoiesis are conserved from mice to humans (Migliaccio
et al., 1986; Huyhn et al., 1995; Palis and Yoder, 2001). As was the
case in themouse system, human pluripotent stem cells could also
be differentiated into cells representative of the early hematopoi-
etic developmental stages, albeit with extended kinetics (Wang
et al., 2004; Zambidis et al., 2005; Kennedy et al., 2007), sug-
gesting that hematopoietic cell emergence in the YS might be
closely modeled by human ESC differentiation (Zambidis et al.,
2005).
Given their direct ontogenetic relationship, we postulate
that techniques for directing primitive macrophage fate spec-
ification from pluripotent stem cells will also yield microglial
precursors. Our proposed approach is to further refine pro-
tocols for recapitulating YS hematopoiesis, with the aim of
increasing the yield of primitive macrophages and levels of
reproducibility. Serum-based protocols introduce intrinsic vari-
ability, so we will turn to a defined serum-free and feeder cell-
free procedure, using only specific combinations of cytokines
to replicate the developmental signals during embryogenesis.
The key challenge in this approach will be to screen appro-
priate combinations of factors as well as the time window
for treatment. Candidate primitive macrophage/microglial cells
can then be isolated based on surface marker expression, and
assayed for microglial-appropriate phenotypes such as response
to immune stimulation, morphological analysis and phago-
cytic ability (Giulian and Baker, 1986; Sedgwick et al., 1991).
Eventually, the ability to engraft within the brain, with classic
resting microglial morphology will be the true test of successful
differentiation.
CONCLUSION
The “origin of murine microglia controversy” is now resolved
in steady state conditions and in a few mouse models of CNS
pathologies. We have learned that microglia arise from YS
macrophages that seed the brain rudiment from the cephalic
mesenchyme very early during development, as predicted ear-
lier by the founder of the microglia field, Pio del Rio-Hortega.
Importantly, embryonically-derived microglia will maintain
themselves until adulthood. While much progress has been made
in terms of our understanding of both the origin and importance
of microglia, many questions remain unanswered.
As discussed before, this knowledge may have implications
for the use of embryonically-derived microglial progenitors in
the treatment of brain inflammatory diseases. Moreover, these
results have fundamental implications for the understanding of
microglial function in CNS development. First, the conservation
of primitive macrophages and their YS derivation throughout
evolution and across diverse species suggests that microglia
play an important physiological role in the development of the
CNS. Furthermore, microglial cells are present in all stages of
brain development, including the early prenatal stages of neu-
ronal circuit building as well as the post-natal stage of synapse
elimination.
An earlier report had highlighted that, in contrast to their
broad distribution in the adult brain, embryonic microglia have a
strikingly uneven distribution during embryogenesis (Perry et al.,
1985). Microglial cells accumulate in hot spots that were initially
proposed to be most likely related to the clearance of apoptotic
bodies and the remodeling of brain tissues. In light of the recent
work which has shown that microglia contribute to the control
of synaptic connections, it will be interesting to verify whether
such hotspots co-localize with areas crucial for neuronal devel-
opment. This will indicate that microglia play an important role
in development of neuronal circuits of the brain and proposes
more questions to be answered regarding the integrated develop-
ment of the neural and immune systems. Such questions also have
tremendous implications beyond the simple biology of microglia.
Do defects affecting microglial development have a long-term
impact on the functional vulnerability of CNS? And do defects in
microglial function perhaps contribute to synaptic abnormalities
seen in some neurodevelopmental disorders? In support of such
hypotheses, prenatal inflammation, which triggers the activation
of microglia, is thought to be a risk factor for the development
of neuropsychiatric disorders such as schizophrenia and autism
spectrum disorders in the unborn child (Patterson, 2009, 2011).
Importantly, embryonic microglia will maintain themselves
until adulthood via local proliferation during late gestation and
post-natal development as well as in the injured adult brain
in reaction to inflammation. They are unlikely to be replaced
by blood-derived monocytes or any bone marrow-derived cells.
Nevertheless, during certain inflammatory conditions found for
example after bone marrow transplantation or in chronic neu-
rodegenerative diseases such asMultiple Sclerosis and Alzheimer’s
disease (Simard and Rivest, 2006; Jung and Schwartz, 2012), the
recruitment of monocytes or other bonemarrow-derived progen-
itors can supplement the microglial population to some extent,
but we do not understand whether these cells persist and become
integrated, or are a temporary addition to the endogenous pop-
ulation. The interactive dynamic between embryonic and adult
microglial populations requires further study: We need now to
understand to what extent the endogenous microglia is replaced,
where and how it is done, and if engrafted cells have a selec-
tive advantage over the endogenous microglia, how well they
“compete” against the endogenous embryonic microglial popu-
lation and how long they will persist. Finally, we do not know yet
precisely if these bone marrow-derived microglia can fulfill the
functional roles of the endogenous population.
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